GNPX
Genprex Inc
NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY
$0.98
+12.07% today
Updated 2026-04-30
Market cap
$8.41M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-17.40
Dividend yield
—
52W range
$1 – $55
Volume
1.1M
Genprex Inc (GNPX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-688261.00 | $-1.25M | $-2.17M | $-6.85M | $-6.92M | $-13.94M | $-14.28M | $-17.78M | $-24.74M | $-17.15M | $-15.31M |
| Capital expenditures | $21284.00 | $89534.00 | $63421.00 | $103317.00 | $946899.00 | $2.34M | $83796.00 | $4.00 | $71383.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $441380.00 | $2.66M | $1.32M | $5.44M | $3.53M | $4.25M | $5.35M | $4.73M | $5.41M | $3.30M | $312835.00 |
| Free cash flow | $-709545.00 | $-1.34M | $-2.24M | $-6.95M | $-7.87M | $-16.27M | $-14.37M | $-17.78M | $-24.81M | $-17.15M | $-15.31M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | — | — | — | — | — | — | $277.12M | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-1.44M | $8.44M | $-6.60M | $25.32M | — | — | — | — | — |